How the ISCO is working toward a ground-breaking cure for Parkinson's disease

By Admin
In an effort to cure Parkinsons disease, Carlsbad, Calif.-based International Stem Cell Corporation (ISCO) will have a world-first trial in Australia fo...

In an effort to cure Parkinson’s disease, Carlsbad, Calif.-based International Stem Cell Corporation (ISCO) will have a world-first trial in Australia for an innovative stem cell therapy.

Australia was chosen to host phase one of the trial due to the nation’s high standard in clinical research as well as its culture of innovation. If the first phase is deemed successful, larger trials in the U.S., Australia and Europe will commence within the next couple years.

RELATED TOPIC: Google's New Wristband Could Treat Parkinson's and Cancer

The trial consists of 12 Parkinson’s patients who will be injected with neural stem cells, and then observed for one year. Doctors will monitor the subjects to see if they are able to boost the brain’s capacity to produce and release the chemical messenger dopamine, which is lost in Parkinson’s patients.

“Dopamine is one of the most critical neurotransmitters or chemical messengers in the brain, and the loss of this neurotransmitter is directly linked to the development of the cardinal features that include stiffness, slowness and shaking,” said Australian neurologist Dr. Andrew Evans.

RELATED TOPIC: How Canada's stem cell research breakthrough will alter medical practices

“It’s hoped that through replenishment of the dopamine through these neural stem cells, which show some capacity to differentiate into obviously dopamine producing cells in the annual models, we are hoping to restore some of the functions in patients with Parkinson’s disease.”

Parkinson’s disease affects nearly 10,000 people across the globe, with symptoms including movement restrictions, shaking, dementia and other behavioral problems. According to ISCO chief scientific officer Dr. Russell Kern, a single injection of the stem cells could generate a lifetime supply of neurons.

RELATED TOPIC: Google Australia leads charge in improving STEM studies

Successful preliminary and subsequent trials would be a revolutionary breakthrough for using stem cells to treat other diseases that cause brain degeneration, including ALS or Lou Gehrig’s disease.

Let's connect!   

Click here to read the latest edition of Healthcare Global magazine!

 

 

Share

Featured Articles

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Three months on, the cyberattack on UnitedHealth Group's Change Healthcare is still affecting US citizens, with delays and

McKinsey: National E-health Initiatives on the Rise

McKinsey report on countries that are scaling national e-health programmes says it is easing financial pressures on healthcare systems globally

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma

London Hospitals Cyberattack Wreaks Healthcare Havoc

Technology & AI

Healthcare Provision in India: Challenges and Opportunities

Health Insurance & Finance